TMCnet News
Research and Markets: India Active Pharmaceutical Ingredients (API) Market Report 2015-2019 with Aurobindo Pharma, Cipla & Dr. Reddy's Laboratories DominatingResearch and Markets (http://www.researchandmarkets.com/research/42rmj8/active) has announced the addition of the "Active Pharmaceutical Ingredients (API) Market in India 2015-2019" report to their offering. The API market in India to grow at a CAGR of 10.76% over the period 2014-2019 Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis. One major trend emeging in this market is the strong focus on the development and introduction of high-potency API. Such products are increasingly used in oncology and for the provision of targeted therapy. According to the report, one of the key drivers contributing to the growth of the API market in India is the increased outsourcing of API by global pharmaceutical companies to low-cost vendors in India. This is done to reduce both manufacturing and infrastructure costs. Further, the report states that stringent regulations are one of the major challenges that the market faces. Such regulations are particularly well defined for the export of products to developed regions such as Western Europe and North America. Vendors are required to comply with elaborate procedures prior to product commercialization. Key Vendors
Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/42rmj8/active |
